Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Touyun Tech Group ( (HK:1332) ) has provided an announcement.
Touyun Biotech Group Limited has announced that its subsidiary, Shanxi Touyun Biotechnology Co., Ltd., has failed to repay a loan of RMB90 million by its maturity date, resulting in an aggregated overdue loan amount of RMB150 million. The company is currently negotiating with the lender for partial repayment and an extension of the repayment date, with the non-payment potentially impacting the Group’s operations.
The most recent analyst rating on (HK:1332) stock is a Hold with a HK$0.30 price target. To see the full list of analyst forecasts on China Touyun Tech Group stock, see the HK:1332 Stock Forecast page.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates in the biotechnology sector, focusing on innovative solutions and products through its subsidiaries, including Shanxi Touyun Biotechnology Co., Ltd.
Average Trading Volume: 4,790,232
Technical Sentiment Signal: Buy
Current Market Cap: HK$771.6M
For an in-depth examination of 1332 stock, go to TipRanks’ Overview page.